Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Kiora Pharmaceuticals (KPRX) Return on Equity (2016 - 2025)

Kiora Pharmaceuticals (KPRX) has disclosed Return on Equity for 11 consecutive years, with 0.39% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Equity fell 54.0% year-over-year to 0.39%, compared with a TTM value of 0.39% through Sep 2025, down 54.0%, and an annual FY2024 reading of 0.22%, changed N/A over the prior year.
  • Return on Equity was 0.39% for Q3 2025 at Kiora Pharmaceuticals, up from 0.52% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.23% in Q1 2024 and bottomed at 2.5% in Q3 2022.
  • Average Return on Equity over 5 years is 0.7%, with a median of 0.51% recorded in 2025.
  • The sharpest move saw Return on Equity tumbled -245bps in 2022, then skyrocketed 162bps in 2024.
  • Year by year, Return on Equity stood at 0.87% in 2021, then tumbled by -185bps to 2.5% in 2022, then soared by 40bps to 1.49% in 2023, then soared by 109bps to 0.13% in 2024, then tumbled by -402bps to 0.39% in 2025.
  • Business Quant data shows Return on Equity for KPRX at 0.39% in Q3 2025, 0.52% in Q2 2025, and 0.49% in Q1 2025.